{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:19:07Z","timestamp":1763572747763},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Menopausal status has a known relationship with the levels of estrogen, progesterone, and other sex hormones, potentially influencing the activity of ER, PR, and many other signaling pathways involved in the initiation and progression of breast cancer. However, the differences between premenopausal and postmenopausal breast cancer patients at the molecular level are unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrieved eight datasets from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) associated with menopausal status in breast cancer patients were identified using the MAMA and LIMMA methods. Based on these validated DEGs, we performed Gene Ontology (GO) functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. Protein\u2013protein interaction (PPI) networks were constructed. We used DrugBank data to investigate which of these validated DEGs are targetable. Survival analysis was performed to explore the influence of these genes on breast cancer patient prognosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 762 DEGs associated with menopausal status in breast cancer patients. PPI network analysis indicated that these genes are primarily involved in pathways such as the cell cycle, oocyte meiosis and progesterone-mediated oocyte maturation pathways. Notably, several genes played roles in multiple signaling pathways and were associated with patient survival. These genes were also observed to be targetable according to the DrugBank database.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We identified DEGs associated with menopausal status in breast cancer patients. The association of these genes with several key pathways may promote understanding of the complex characterizations of breast cancer. Our findings offer valuable insights for developing new therapeutic strategies tailored to the menopausal status of breast cancer patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-023-02846-7","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T19:02:58Z","timestamp":1704222178000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of genes and pathways associated with menopausal status in breast cancer patients using two algorithms"],"prefix":"10.1186","volume":"24","author":[{"given":"Minzhang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanlu","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"issue":"3","key":"2846_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"2846_CR2","doi-asserted-by":"publisher","first-page":"a003178","DOI":"10.1101\/cshperspect.a003178","volume":"2","author":"C Brisken","year":"2010","unstructured":"Brisken C, O'Malley B. Hormone action in the mammary gland. Cold Spring Harb Perspect Biol. 2010;2(12):a003178.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"10","key":"2846_CR3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1001\/jama.2017.11217","volume":"318","author":"JE Manson","year":"2017","unstructured":"Manson JE, Aragaki AK, Rossouw JE, et al. Menopausal hormone therapy and Long-term all-cause and cause-specific mortality: the Women's Health Initiative randomized trials. JAMA. 2017;318(10):927\u201338.","journal-title":"JAMA"},{"issue":"8","key":"2846_CR4","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","volume":"8","author":"E Heer","year":"2020","unstructured":"Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health. 2020;8(8):e1027\u201337.","journal-title":"Lancet Glob Health"},{"issue":"10204","key":"2846_CR5","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0140-6736(19)32033-1","volume":"394","author":"V Beral","year":"2019","unstructured":"Beral V, Peto R, Pirie K, Reeves G. Menopausal hormone therapy and 20-year breast cancer mortality. Lancet. 2019;394(10204):1139.","journal-title":"Lancet"},{"issue":"10204","key":"2846_CR6","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","volume":"394","author":"Collaborative Group on Hormonal Factors in Breast C","year":"2019","unstructured":"Collaborative Group on Hormonal Factors in Breast C. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet. 2019;394(10204):1159\u201368.","journal-title":"Lancet"},{"issue":"2","key":"2846_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","volume":"4","author":"RA Irizarry","year":"2003","unstructured":"Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249\u201364.","journal-title":"Biostatistics"},{"key":"2846_CR8","first-page":"7730","volume":"2005","author":"Z Zhang","year":"2005","unstructured":"Zhang Z, Fenstermacher D. An introduction to MAMA (Meta-analysis of MicroArray data) system. Conf Proc IEEE Eng Med Biol Soc. 2005;2005:7730\u20133.","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"issue":"7","key":"2846_CR9","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"2846_CR10","doi-asserted-by":"publisher","first-page":"W199","DOI":"10.1093\/nar\/gkz401","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao Y, Wang J, Jaehnig EJ, Shi Z, Zhang B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019;47(W1):W199\u2013205.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2846_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2846_CR12","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"2846_CR13","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"key":"2846_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003;4:2.","journal-title":"BMC Bioinformatics"},{"key":"2846_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.12688\/f1000research.4392.1","volume":"3","author":"JH Morris","year":"2014","unstructured":"Morris JH, Lotia S, Wu A, et al. setsApp for Cytoscape: set operations for Cytoscape nodes and edges. F1000Research. 2014;3:149.","journal-title":"F1000Research"},{"issue":"D1","key":"2846_CR16","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074\u201382.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"2846_CR17","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1158\/0008-5472.CAN-14-0673","volume":"76","author":"P den Hollander","year":"2016","unstructured":"den Hollander P, Rawls K, Tsimelzon A, et al. Phosphatase PTP4A3 promotes triple-negative breast Cancer growth and predicts poor patient survival. Cancer Res. 2016;76(7):1942\u201353.","journal-title":"Cancer Res"},{"issue":"8","key":"2846_CR18","doi-asserted-by":"publisher","first-page":"e66848","DOI":"10.1371\/journal.pone.0066848","volume":"8","author":"O Metzger-Filho","year":"2013","unstructured":"Metzger-Filho O, Catteau A, Michiels S, et al. Genomic grade index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancer. PLoS One. 2013;8(8):e66848.","journal-title":"PLoS One"},{"issue":"10","key":"2846_CR19","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1158\/1078-0432.CCR-12-2986","volume":"19","author":"KD Yu","year":"2013","unstructured":"Yu KD, Zhu R, Zhan M, et al. Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer. Clin Cancer Res. 2013;19(10):2723\u201333.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2846_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1158\/1078-0432.CCR-13-0239","volume":"20","author":"A Prat","year":"2014","unstructured":"Prat A, Bianchini G, Thomas M, et al. Research-based PAM50 subtype predictor identifies higher responses and improved survival outcomes in HER2-positive breast cancer in the NOAH study. Clin Cancer Res. 2014;20(2):511\u201321.","journal-title":"Clin Cancer Res"},{"key":"2846_CR21","doi-asserted-by":"crossref","unstructured":"Shike M, Doane AS, Russo L, et al. The effects of soy supplementation on gene expression in breast cancer: a randomized placebo-controlled study. J Natl Cancer Inst. 2014;106(9):dju189.","DOI":"10.1093\/jnci\/dju189"},{"issue":"11","key":"2846_CR22","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1158\/1535-7163.MCT-15-0252","volume":"14","author":"J Xiang","year":"2015","unstructured":"Xiang J, Hurchla MA, Fontana F, et al. CXCR4 protein epitope mimetic antagonist POL5551 disrupts metastasis and enhances chemotherapy effect in triple-negative breast Cancer. Mol Cancer Ther. 2015;14(11):2473\u201385.","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"2846_CR23","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","volume":"21","author":"MD Burstein","year":"2015","unstructured":"Burstein MD, Tsimelzon A, Poage GM, et al. Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res. 2015;21(7):1688\u201398.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2846_CR24","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1158\/1078-0432.CCR-20-2662","volume":"27","author":"K Edlund","year":"2021","unstructured":"Edlund K, Madjar K, Lebrecht A, et al. Gene expression-based prediction of Neoadjuvant chemotherapy response in early breast Cancer: results of the prospective multicenter EXPRESSION trial. Clin Cancer Res. 2021;27(8):2148\u201358.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2846_CR25","doi-asserted-by":"publisher","first-page":"e13525","DOI":"10.1111\/eci.13525","volume":"51","author":"L Wang","year":"2021","unstructured":"Wang L, Mo C, Wang L, Cheng M. Identification of genes and pathways related to breast cancer metastasis in an integrated cohort. Eur J Clin Investig. 2021;51(7):e13525.","journal-title":"Eur J Clin Investig"},{"issue":"8","key":"2846_CR26","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nrc864","volume":"2","author":"KH Vousden","year":"2002","unstructured":"Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer. 2002;2(8):594\u2013604.","journal-title":"Nat Rev Cancer"},{"issue":"26","key":"2846_CR27","doi-asserted-by":"publisher","first-page":"18258","DOI":"10.1074\/jbc.M114.547208","volume":"289","author":"CT Cheung","year":"2014","unstructured":"Cheung CT, Singh R, Kalra RS, Kaul SC, Wadhwa R. Collaborator of ARF (CARF) regulates proliferative fate of human cells by dose-dependent regulation of DNA damage signaling. J Biol Chem. 2014;289(26):18258\u201369.","journal-title":"J Biol Chem"},{"key":"2846_CR28","doi-asserted-by":"publisher","first-page":"970950","DOI":"10.3389\/fimmu.2022.970950","volume":"13","author":"T Cheng","year":"2022","unstructured":"Cheng T, Wu Y, Liu Z, et al. CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer. Front Immunol. 2022;13:970950.","journal-title":"Front Immunol"},{"issue":"6","key":"2846_CR29","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1006\/mthe.2002.0602","volume":"5","author":"HY Shi","year":"2002","unstructured":"Shi HY, Liang R, Templeton NS, Zhang M. Inhibition of breast tumor progression by systemic delivery of the maspin gene in a syngeneic tumor model. Mol Ther. 2002;5(6):755\u201361.","journal-title":"Mol Ther"},{"issue":"10","key":"2846_CR30","first-page":"593","volume":"8","author":"J Wu","year":"1988","unstructured":"Wu J, Chen KJ. Platelet ultrastructure and function of coronary heart disease in patients with the blood-stasis symptom-complex. Zhong Xi Yi Jie He Za Zhi. 1988;8(10):593\u20135. 581","journal-title":"Zhong Xi Yi Jie He Za Zhi"},{"issue":"17","key":"2846_CR31","doi-asserted-by":"publisher","first-page":"9720","DOI":"10.1016\/S0021-9258(17)39298-0","volume":"260","author":"CJ Allegra","year":"1985","unstructured":"Allegra CJ, Chabner BA, Drake JC, Lutz R, Rodbard D, Jolivet J. Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates. J Biol Chem. 1985;260(17):9720\u20136.","journal-title":"J Biol Chem"},{"issue":"23","key":"2846_CR32","first-page":"6556","volume":"49","author":"H Arkin","year":"1989","unstructured":"Arkin H, Ohnuma T, Kamen BA, Holland JF, Vallabhajosula S. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate. Cancer Res. 1989;49(23):6556\u201361.","journal-title":"Cancer Res"},{"issue":"4","key":"2846_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0006-2952(99)00320-2","volume":"59","author":"MJ Barnes","year":"2000","unstructured":"Barnes MJ, Taylor GA, Newell DR. Development of a whole cell assay to measure methotrexate-induced inhibition of thymidylate synthase and de novo purine synthesis in leukaemia cells. Biochem Pharmacol. 2000;59(4):321\u20138.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"2846_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1634\/stemcells.18-3-166","volume":"18","author":"D Papamichael","year":"2000","unstructured":"Papamichael D. The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status. Stem Cells. 2000;18(3):166\u201375.","journal-title":"Stem Cells"},{"issue":"4","key":"2846_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drup.2012.07.002","volume":"15","author":"N Gonen","year":"2012","unstructured":"Gonen N, Assaraf YG. Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance. Drug Resist Updat. 2012;15(4):183\u2013210.","journal-title":"Drug Resist Updat"},{"key":"2846_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-2407-13-47","volume":"13","author":"E Shubbar","year":"2013","unstructured":"Shubbar E, Helou K, Kovacs A, et al. High levels of gamma-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer. BMC Cancer. 2013;13:47.","journal-title":"BMC Cancer"},{"issue":"36","key":"2846_CR37","doi-asserted-by":"publisher","first-page":"9408","DOI":"10.1200\/JCO.2005.01.5594","volume":"23","author":"GK Schwartz","year":"2005","unstructured":"Schwartz GK, Shah MA. Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol. 2005;23(36):9408\u201321.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2846_CR38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/00003081-198206000-00021","volume":"25","author":"DJ Marchant","year":"1982","unstructured":"Marchant DJ. Epidemiology of breast cancer. Clin Obstet Gynecol. 1982;25(2):387\u201392.","journal-title":"Clin Obstet Gynecol"},{"issue":"2","key":"2846_CR39","doi-asserted-by":"publisher","first-page":"12431","DOI":"10.1080\/21655979.2021.2005747","volume":"12","author":"N Wang","year":"2021","unstructured":"Wang N, Zhang H, Li D, Jiang C, Zhao H, Teng Y. Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation. Bioengineered. 2021;12(2):12431\u201346.","journal-title":"Bioengineered"},{"issue":"8","key":"2846_CR40","first-page":"4329","volume":"37","author":"Z Liu","year":"2017","unstructured":"Liu Z, Liang G, Tan L, Su AN, Jiang W, Gong C. High-efficient screening method for identification of key genes in breast Cancer through microarray and bioinformatics. Anticancer Res. 2017;37(8):4329\u201335.","journal-title":"Anticancer Res"},{"key":"2846_CR41","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.12659\/MSM.904789","volume":"23","author":"LF Dong","year":"2017","unstructured":"Dong LF, Xu SY, Long JP, Wan F, Chen YD. RNA-sequence analysis reveals differentially expressed genes (DEGs) in patients exhibiting different risks of tumor metastasis. Med Sci Monit. 2017;23:2842\u20139.","journal-title":"Med Sci Monit"},{"issue":"1","key":"2846_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10552-005-0429-9","volume":"17","author":"DG Cox","year":"2006","unstructured":"Cox DG, Hankinson SE, Hunter DJ. Polymorphisms of the AURKA (STK15\/Aurora kinase) gene and Breast Cancer risk (United States). Cancer Causes Control. 2006;17(1):81\u20133.","journal-title":"Cancer Causes Control"},{"issue":"47","key":"2846_CR43","doi-asserted-by":"publisher","first-page":"77358","DOI":"10.18632\/oncotarget.12669","volume":"7","author":"DG Cox","year":"2016","unstructured":"Cox DG, Curtit E, Romieu G, et al. GWAS in the SIGNAL\/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients. Oncotarget. 2016;7(47):77358\u201364.","journal-title":"Oncotarget"},{"issue":"1","key":"2846_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1023\/A:1013960609008","volume":"13","author":"RE Tarone","year":"2002","unstructured":"Tarone RE, Chu KC. The greater impact of menopause on ER- than ER+ breast cancer incidence: a possible explanation (United States). Cancer Causes Control. 2002;13(1):7\u201314.","journal-title":"Cancer Causes Control"},{"issue":"3","key":"2846_CR45","first-page":"187","volume":"12","author":"A Fenton","year":"2021","unstructured":"Fenton A. Weight, shape, and body composition changes at menopause. J Midlife Health. 2021;12(3):187\u201392.","journal-title":"J Midlife Health"},{"issue":"4","key":"2846_CR46","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3390\/cancers7040883","volume":"7","author":"DP Rose","year":"2015","unstructured":"Rose DP, Gracheck PJ, Vona-Davis L. The interactions of obesity, inflammation and insulin resistance in breast Cancer. Cancers. 2015;7(4):2147\u201368.","journal-title":"Cancers"},{"issue":"2","key":"2846_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1515\/hmbci-2013-0007","volume":"14","author":"JA Eden","year":"2013","unstructured":"Eden JA. Menopausal status, adipose tissue, and breast cancer risk: impact of estrogen replacement therapy. Horm Mol Biol Clin Investig. 2013;14(2):57\u201363.","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"5","key":"2846_CR48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1039\/C8MO00128F","volume":"14","author":"L Yang","year":"2018","unstructured":"Yang L, Wang S, Zhang Q, et al. Clinical significance of the immune microenvironment in ovarian cancer patients. Mol Omics. 2018;14(5):341\u201351.","journal-title":"Mol Omics"},{"issue":"2","key":"2846_CR49","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1093\/bib\/bbaa026","volume":"22","author":"S Wang","year":"2021","unstructured":"Wang S, Zhang Q, Yu C, Cao Y, Zuo Y, Yang L. Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer. Brief Bioinform. 2021;22(2):2020\u201331.","journal-title":"Brief Bioinform"},{"key":"2846_CR50","doi-asserted-by":"crossref","unstructured":"Wang S, Xiong Y, Zhang Q, et al. Clinical significance and immunogenomic landscape analyses of the immune cell signature based prognostic model for patients with breast cancer. Brief Bioinform. 2021;22(4):bbaa311.","DOI":"10.1093\/bib\/bbaa311"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02846-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02846-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02846-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T19:04:03Z","timestamp":1704222243000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02846-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2846"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02846-7","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"14 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}